We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Lonza Introduces Nucleofector™ PLUS Supplements

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Lonza has introduced Nucleofector™ PLUS Supplements, a new add-on product for use in combination with Nucleofector™ Kits.

These specialized supplements which are used instead of the standard kit supplement allow cryopreservation of freshly isolated or harvested cells in Nucleofector™ Solution.

“By decoupling cell harvesting and transfection, Nucleofection™ Experiments can be done at the scientist’s convenience. Cells can be collected, stored and are ready-to-use at a later time, and deliver transfection results comparable to fresh cells. Larger cell batches can be cryopreserved so that researchers can avoid batch-to-batch variances in transfection results. Thus, Nucleofector™ PLUS Supplements can make whole experimental programs more consistent.” explains Dr. Herbert Mueller-Hartmann, Head of R&D Discovery Technologies.

Nucleofection™ is a transfection technology that was first introduced into the market in 2001. It is based on the unique combination of electrical parameters and cell-type specific solutions.

It is known as the first efficient non-viral transfection method for primary neural cells and has been stated in over 300 peer-reviewed publications as the method of choice for transfection of primary neurons.